Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Orthopediatrics Corp

2X7
Current price
22.8 EUR 0 EUR (0.00%)
Last closed 24.26 USD
ISIN US68752L1008
Sector Healthcare
Industry Medical Devices
Exchange Frankfurt Exchange
Capitalization 604 913 152 USD
Yield for 12 month -26.34 %
1Y
3Y
5Y
10Y
15Y
2X7
21.11.2021 - 28.11.2021

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana. Address: 2850 Frontier Drive, Warsaw, IN, United States, 46582

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

40.67 USD

P/E ratio

Dividend Yield

Current Year

+148 732 000 USD

Last Year

+122 289 000 USD

Current Quarter

+54 573 000 USD

Last Quarter

+52 802 000 USD

Current Year

+93 868 000 USD

Last Year

+90 660 000 USD

Current Quarter

+40 060 000 USD

Last Quarter

+36 020 000 USD

Key Figures 2X7

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -8 747 000 USD
Operating Margin TTM -10.2 %
PE Ratio
Return On Assets TTM -3.94 %
PEG Ratio
Return On Equity TTM -7.63 %
Wall Street Target Price 40.67 USD
Revenue TTM 189 672 992 USD
Book Value 15.32 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 36.5 %
Dividend Yield
Gross Profit TTM 90 660 000 USD
Earnings per share -1.23 USD
Diluted Eps TTM -1.23 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -15 %

Dividend Analytics 2X7

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 2X7

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 2X7

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 3.2658
Price Sales TTM 3.2837
Enterprise Value EBITDA -79.8553
Price Book MRQ 1.6792

Financials 2X7

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 2X7

For 52 weeks

24.02 USD 36.23 USD
50 Day MA 27.76 USD
Shares Short Prior Month 961 694
200 Day MA 29.23 USD
Short Ratio 5.7
Shares Short 929 620
Short Percent 13.99 %